Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Psychedelics produce enduring enhancement of reward responsiveness in male rats
    Published on 2026-07-10
    2 months ago
  • The neuroanatomy of depression: weak but replicable effects in 4021 individuals from three clinical cohorts
    Published on 2026-07-10
    2 months ago
  • Does a monoclonal antibody targeting immune cells affect glutamatergic level in schizophrenia? A multimodal PET/MRS brain imaging study
    Published on 2026-07-09
    2 months ago
  • Correction: Cue labeling reduces cigarette craving and associated neural activity
    Published on 2026-07-08
    2 months ago
  • In memoriam – Ming T. Tsuang, M.D., Ph.D., D.Sc
    Published on 2026-07-08
    2 months ago
  • Long-term effects of adolescent risperidone treatment on the mouse cortex
    Published on 2026-07-08
    2 months ago
  • Pharmacokinetics and concentration-behavioral effect relationships differ between brain subcompartments
    Published on 2026-07-07
    2 months ago
« Previous 1 … 9 10 11 12 13 … 143 Next »
Journal of Psychopharmacology
  • Oxytocin prevents ketamine-induced executive control deficits in macaque monkeys
    Published on 2026-05-08
    4 months ago
  • Cardiovascular mortality and depression: A systematic review and meta-analysis of the association with antidepressant treatment and co-morbidity
    Published on 2026-05-08
    4 months ago
  • Effects of benzodiazepines on saccadic eye movements: A systematic review and meta-analysis
    Published on 2026-05-04
    4 months ago
  • 5-HT1A receptor blockade potentiates the subjective effects of DMT
    Published on 2026-05-02
    4 months ago
  • Effects of psychedelic use on authoritarian attitudes revisited
    Published on 2026-05-02
    4 months ago
  • Preliminary evidence that serum interleukin-6 is a candidate biomarker of response to esketamine in treatment-resistant depression
    Published on 2026-04-25
    5 months ago
  • The effects of the PDE4 inhibitor roflumilast on cognitive performance after a cerebrovascular accident: a double-blind randomized placebo-controlled trial with an open label extension (ROSTMEMA)
    Published on 2026-04-25
    5 months ago
« Previous 1 … 9 10 11 12 13 … 154 Next »
European Neuropsychopharmacology
  • Evidence of phenotypes indexing cognitive resilience and vulnerability in the early course of mood and psychosis spectrum illness; mapping the latent structure, characteristics, and longitudinal stability of cognitive heterogeneity
    Published on 2026-03-10
    6 months ago
  • Is the time ripe for psychiatry to adopt a “mental health engineering” lens?
    Published on 2026-03-10
    6 months ago
  • Involuntary movements integral to psychotic illness: a ‘circular epistemological journey’ informing the pathobiology and treatment of psychosis and reconceptualising tardive dyskinesia
    Published on 2026-03-06
    6 months ago
  • Critical considerations on the trial of FAAH inhibitor JNJ-42165279 in major depressive disorder with anxious distress
    Published on 2026-02-28
    7 months ago
  • Unraveling the genetic architecture of depression-atherosclerosis comorbidity: a paradigm shift in understanding mind-heart connections
    Published on 2026-02-27
    7 months ago
  • Methodological points for consideration: Enhancing the interpretation of the COH-FIT findings
    Published on 2026-02-27
    7 months ago
  • Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study
    Published on 2026-02-27
    7 months ago
« Previous 1 … 9 10 11 12 13 … 170 Next »

   Pharma Pub